A carregar...
Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies
Over the past years, progress has been made in cancer immunotherapy following the development of immune checkpoint inhibitors (ICI) that have been proved effective in the management of many malignancies. Ipilimumab, a monoclonal antibody against cytotoxic T-lymphocyte antigen-4 (CTLA-4), has been ap...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537807/ https://ncbi.nlm.nih.gov/pubmed/33061641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S224791 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|